A detailed history of Schechter Investment Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Schechter Investment Advisors, LLC holds 38,455 shares of ABBV stock, worth $7.71 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
38,455
Previous 35,625 7.94%
Holding current value
$7.71 Million
Previous $6.49 Million 1.66%
% of portfolio
0.68%
Previous 0.63%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$154.79 - $180.76 $438,055 - $511,550
2,830 Added 7.94%
38,455 $6.6 Million
Q1 2024

May 06, 2024

SELL
$159.82 - $182.1 $5,593 - $6,373
-35 Reduced 0.1%
35,625 $6.49 Million
Q4 2023

Jan 17, 2024

BUY
$137.6 - $154.97 $9,907 - $11,157
72 Added 0.2%
35,660 $5.53 Million
Q3 2023

Nov 06, 2023

BUY
$133.59 - $154.65 $175,670 - $203,364
1,315 Added 3.84%
35,588 $5.3 Million
Q2 2023

Jul 26, 2023

SELL
$132.51 - $164.9 $783,266 - $974,723
-5,911 Reduced 14.71%
34,273 $4.62 Million
Q1 2023

Apr 28, 2023

SELL
$144.61 - $166.54 $246,560 - $283,950
-1,705 Reduced 4.07%
40,184 $6.4 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $52,419 - $62,864
379 Added 0.91%
41,889 $6.77 Million
Q3 2022

Nov 04, 2022

SELL
$134.21 - $153.93 $12,481 - $14,315
-93 Reduced 0.22%
41,510 $5.57 Million
Q2 2022

Nov 03, 2022

BUY
$137.62 - $174.96 $5.73 Million - $7.28 Million
41,603 New
41,603 $6.37 Million
Q1 2022

Nov 18, 2022

BUY
$131.98 - $163.75 $180,416 - $223,846
1,367 Added 3.29%
42,877 $6.95 Million
Q4 2021

Dec 27, 2022

BUY
$107.43 - $135.93 $241,824 - $305,978
2,251 Added 5.42%
43,761 $5.93 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Schechter Investment Advisors, LLC Portfolio

Follow Schechter Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schechter Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schechter Investment Advisors, LLC with notifications on news.